G3 Pharmaceuticals
PrivateCompany Overview
G3 Pharmaceuticals operates in Healthcare & Life Sciences and is based in Lexington, Massachusetts. It was founded in 2017.
G3 Pharmaceuticals is a biopharmaceutical company that develops carbohydrate-based galectin-3 inhibitors for the treatment of cardiovascular and renal diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
G3 Pharmaceuticals Comparables
Compare G3 Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| GlycoMantra | 84% | |
| MandalMed, Inc. | 78% |
For institutional investors. Book with your work email.
G3 Pharmaceuticals Funding Rounds
Historical fundraising activity
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
G3 Pharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about G3 Pharmaceuticals's valuation, stock price, and market status.
Is G3 Pharmaceuticals a public or private company?
G3 Pharmaceuticals is a private company.
What is the current stock price of G3 Pharmaceuticals?
G3 Pharmaceuticals is a private company, so its shares have no public market price. Caplight tracks G3 Pharmaceuticals's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is G3 Pharmaceuticals worth (valuation)?
Valuation information for G3 Pharmaceuticals is not publicly available.
Can I buy G3 Pharmaceuticals stock?
G3 Pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was G3 Pharmaceuticals's last funding round?
Funding round information for G3 Pharmaceuticals is not publicly available.
Who are the main investors in G3 Pharmaceuticals?
Investor information for G3 Pharmaceuticals is not publicly disclosed.
Will G3 Pharmaceuticals IPO soon?
No public IPO plans have been announced for G3 Pharmaceuticals.
How can I track G3 Pharmaceuticals secondary market activity?
Caplight tracks bids, offers, and trades in G3 Pharmaceuticals's shares on secondary markets.